Cargando…

Serum levels of IL-4, IL-13 and IL-33 in patients with age-related macular degeneration and myeloproliferative neoplasms

Immune responses play a key role in the pathogenesis and progression of myeloproliferative neoplasms (MPN) and age-related macular degeneration (AMD). Recent studies suggested using MPNs as a “Human Inflammation Model” of drusen development and previous results showed interleukin-4 (IL-4) dysregulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gotfredsen, Kathrine, Liisborg, Charlotte, Skov, Vibe, Kjær, Lasse, Hasselbalch, Hans Carl, Sørensen, Torben Lykke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008625/ https://www.ncbi.nlm.nih.gov/pubmed/36906669 http://dx.doi.org/10.1038/s41598-023-31078-w

Ejemplares similares

Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers
por: Liisborg, Charlotte, et al.
Publicado: (2022)

Retinal drusen in patients with chronic myeloproliferative blood cancers are associated with an increased proportion of senescent T cells and signs of an aging immune system
por: Liisborg, Charlotte, et al.
Publicado: (2021)

Patients with myeloproliferative neoplasms and high levels of systemic inflammation develop age-related macular degeneration
por: Liisborg, Charlotte, et al.
Publicado: (2020)

Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
por: Liisborg, Charlotte, et al.
Publicado: (2020)

Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation
por: Liisborg, Charlotte, et al.
Publicado: (2021)

Age‐related macular degeneration and myeloproliferative neoplasms – A common pathway
por: Liisborg, Charlotte
Publicado: (2022)

Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer’s disease: evidences and perspectives
por: Hasselbalch, Hans C., et al.
Publicado: (2020)

Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment
por: Kjær, Lasse, et al.
Publicado: (2016)

Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
por: Kjær, Lasse
Publicado: (2020)

The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration
por: Subhi, Yousif, et al.
Publicado: (2019)

Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow
por: Holmström, Morten Orebo, et al.
Publicado: (2023)

Whole Blood Transcriptional Profiling Reveals Deregulation of Oxidative and Antioxidative Defence Genes in Myelofibrosis and Related Neoplasms. Potential Implications of Downregulation of Nrf2 for Genomic Instability and Disease Progression
por: Hasselbalch, Hans Carl, et al.
Publicado: (2014)

Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
por: Čokić, Vladan P., et al.
Publicado: (2015)

Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives
por: Hasselbalch, Hans, et al.
Publicado: (2022)

An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial
por: Grauslund, Jacob Handlos, et al.
Publicado: (2023)

Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression
por: Carnaz Simões, Ana Micaela, et al.
Publicado: (2022)

IL-33, IL-37, and Vitamin D Interaction Mediate Immunomodulation of Inflammation in Degenerating Cartilage †
por: Rai, Vikrant, et al.
Publicado: (2021)

Loss-of-function polymorphism in IL6R reduces risk of JAK2V617F somatic mutation and myeloproliferative neoplasm: A Mendelian randomization study
por: Pedersen, Kasper Mønsted, et al.
Publicado: (2020)

IL-33/IL-31 Axis in Osteoporosis
por: De Martinis, Massimo, et al.
Publicado: (2020)

Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression
por: Simões, Ana Micaela Carnaz, et al.
Publicado: (2022)

Myeloproliferative neoplasms in five multiple sclerosis patients()
por: Thorsteinsdottir, Sigrun, et al.
Publicado: (2013)

Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanisms
por: Skov, Vibe, et al.
Publicado: (2022)

Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
por: Farahani, Rahim, et al.
Publicado: (2014)

IL-33 amplifies an innate immune response in the degenerating retina
por: Xi, Hongkang, et al.
Publicado: (2016)

A complicated liaison: IL-33 and IL-33R in arthritis pathogenesis
por: Kamradt, Thomas, et al.
Publicado: (2013)

IL-33 promotes IL-10 production in macrophages: a role for IL-33 in macrophage foam cell formation
por: Zhang, Hai-Feng, et al.
Publicado: (2017)

IL-33 Enhanced the Proliferation and Constitutive Production of IL-13 and IL-5 by Fibrocytes
por: Hayashi, Hisako, et al.
Publicado: (2014)

Counteractive Effects of IL-33 and IL-37 on Inflammation in Osteoarthritis †
por: Rai, Vikrant, et al.
Publicado: (2022)

Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development
por: Mai, Elaine, et al.
Publicado: (2021)

Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria
por: Lin, Wei, et al.
Publicado: (2017)

IL-33 Mediates Lung Inflammation by the IL-6-Type Cytokine Oncostatin M
por: Botelho, Fernando, et al.
Publicado: (2020)

IL-33 and Airway Inflammation
por: Oboki, Keisuke, et al.
Publicado: (2011)

IL-33 in Mental Disorders
por: Pandolfo, Gianluca, et al.
Publicado: (2021)

IL-33 in Rheumatic Diseases
por: Dong, Yuanji, et al.
Publicado: (2021)

Longitudinal changes in the expression of IL-33 and IL-33 regulated genes in relapsing remitting MS
por: Sriram, Subramaniam, et al.
Publicado: (2018)

Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art
por: Hermouet, Sylvie, et al.
Publicado: (2015)

IL-33/IL-31 Axis: A Potential Inflammatory Pathway
por: Di Salvo, Eleonora, et al.
Publicado: (2018)

IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases
por: Murdaca, Giuseppe, et al.
Publicado: (2019)

Assessment of TSLP, IL 25 and IL 33 in patients with shrimp allergy
por: Ukleja-Sokołowska, Natalia, et al.
Publicado: (2021)

Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis
por: Jou, Eric, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4feup5q8b4a3tfhdjq88nil4ga